DM0000: The mark consists of the letters "KV" in black between two parentheses in black with a red slash across the letters "KV," all placed next to the words "KALIVIR IMMUNOTHERAPEUTICS" in black with the second "I" in "KALIVIR" being red.
CC0000: The color(s) red and black is/are claimed as a feature of the mark.
GS0011: Biological preparations for scientific research purposes
DS0000: "IMMUNOTHERAPEUTICS"
Case File Event Statements
12/4/2021 - 3 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
12/6/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
12/7/2021 - 3 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
9/10/2022 - 2 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
9/19/2022 - 2 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
9/19/2022 - 2 years ago
6 - NON-FINAL ACTION E-MAILEDType:GNRT
9/19/2022 - 2 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
3/20/2023 - a year ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
3/20/2023 - a year ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
3/21/2023 - a year ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
4/25/2023 - a year ago
11 - FINAL REFUSAL WRITTENType:CNFR
4/25/2023 - a year ago
12 - FINAL REFUSAL E-MAILEDType:GNFR
4/25/2023 - a year ago
13 - NOTIFICATION OF FINAL REFUSAL EMAILEDType:GNFN
7/21/2023 - a year ago
14 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVEDType:XELR